Precision Medicine Transformed Oncology —It’s Time to Do the Same for Sepsis
It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable.
Sutter Health Says Flosonic’s Wearable Ultrasound Can Save Lives in the ED
Sutter Health is scaling its use of Flosonics Medical’s wearable ultrasound device, which helps clinicians quickly and noninvasively assess fluid responsiveness. The tool’s ease of use has driven rapid adoption, said Dr. John Skovran, an emergency department medical director at Sutter.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
The Role of Clinical Collaboration Platforms in Enhancing Sepsis Care Workflows
While clinical collaboration platforms have already made a significant impact, there is still much work to be done to ensure that every hospital has the tools and protocols in place to respond to sepsis with the urgency it demands.
Why Hospital EDs Are Adopting Cytovale’s Sepsis Test
A third health system has started using Cytovale’s early sepsis detection test. Froedtert & the Medical College of Wisconsin Health Network announced its plans to deploy the diagnostic test this week.
Cytovale Snags $84M To Commercialize Early Sepsis Detection Test
Cytovale, a San Francisco-based medical diagnostics company, raised $84 million in Series C funds to advance the commercialization of its diagnostic test for early sepsis detection. Using standard blood draws, the test provides results in under 10 minutes. It is meant to detect sepsis in patients who present to hospital emergency departments.
How Geisinger, UNC Health Are Deploying Predictive Algorithms
Executives from Geisinger and UNC Health discussed the most impactful ways they have deployed predictive AI across their health systems during a recent virtual panel. At Geisinger, these predictive algorithms are reducing avoidable emergency department admissions, and at UNC, they are helping to identify sepsis before it becomes severe.
presented by
Closing the Quality-Affordability Gap in Workplace Mental Health
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
Diagnostics firm adds investor to bring funding over $20M
Prenosis is aiming for FDA clearance this year for a diagnostic tool for sepsis, a condition that kills millions of people each year.
Hackensack Meridian Health deploys Google Chrome OS devices, uses Cloud AI for screenings
The New Jersey-based health system initially partnered with Google in 2019. It has now migrated to Google Workspace, providing thousands of Chrome OS devices to remote workers, and is using Google Cloud AI capabilities to detect diseases like breast cancer and Covid-19.
Sepsis: Treating a global health crisis at the point of care
Utilizing POC testing for sepsis is a pragmatic solution for risk-stratification of new patients, helping physicians to prioritize those for treatment based on the severity of their condition.
Popular sepsis prediction model works ‘substantially worse’ than claimed, researchers find
In an analysis of Epic’s sepsis model, researchers at the University of Michigan found that it performed “substantially worse” than what the developer reported. According to their analysis, it didn’t detect many undiagnosed sepsis cases, but still gave alerts for one in five hospitalized patients.
presented by
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
Culture-free alternatives for characterizing bloodstream infections
In the coming years, clinicians will be presented with a larger and more capable toolbox to aid in the diagnosis of sepsis, directly overcoming the drawbacks of culture-based diagnostics.
BOA Biomedical seeks to address antibiotic resistance and sepsis
Harvard’s Wyss Institute and VC firm Miraki Innovation have created a joint venture BOA Biomedical, which is developing a device that could diagnose and treat infectious diseases.
These are the top 10 patient safety challenges in 2019
A report from ECRI Institute outlined the 10 biggest patient safety concerns, and diagnostic errors and improper management of test results in EHRs topped the list.
CLEW Medical leverages AI to predict patient complications
The Israeli startup's analytics platform relies on a hospital's data set and seeks to identify potential complications like sepsis in ICU patients.
Does big data hold the secret to controlling sepsis?
A big data, machine learning-based system could analyze the profiles of patients who have suffered from sepsis and build a profile that would show the specific data readings for each data point, alone and as they interact with other data points.